drugset / Trial / NCT06368063
The Study of Huaier Granule in Postoperative Adjuvant Therapy of Resectable Pancreatic Cancer
Phase 4
Recruiting
642 enrolled
Xi'an Jiaotong University
Huazhong University of Science and Technology · collabLinkDoc Technology (Beijing) Co. Ltd. · collab
Non-randomizedParallel-groupOpen-labelTreatment
Summary
The study is a multicenter, prospective clinical study aimed at evaluating the efficacy and safety of Huaier Granule in postoperative adjuvant treatment of resectable pancreatic cancer
Timeline
- Start
- 2024-05-06
- Primary completion
- 2026-03
- Completion
- 2028-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Capecitabine | Small molecule | — | — |
| Comparator | Gemcitabine | Small molecule | 1000 mg/m2 | Intravenous |
| Subject | Huaier Granule | Traditional medicine (herbal / TCM) | 10 g | Oral |
| Comparator | Ilitacan | Unknown | 150 mg/m2 | Intravenous |
| Comparator | Leucovorin | Small molecule | 400 mg/m2 | Intravenous |
| Comparator | Oxaliplatin | Small molecule | 85 mg/m2 | Intravenous |
| Comparator | Tegio | Unknown | 80 mg | Oral |
| Comparator | fluorouracil | Small molecule | 2400 mg/m2 | Intravenous |